Journal of the American Chemical Society
Communication
This reactivity feature has been utilized in chemical biology
applications, where stabilized diazo compounds have been
developed to label proteins and nucleic acids via O-
alkylation.32 For an α-boryl diazo compound the high
oxophilicity of boron may present an additional challenge to
successfully O-alkylate suitable oxygen-based nucleophiles such
as carboxylic acids. Gratifyingly, we determined that
diazomethyl-1,2-azaborine 1 reacts quite rapidly at room
temperature with carboxylic acids to form esters in acetonitrile
in the absence of a catalyst. As can be seen from Scheme 5, aryl
and alkyl carboxylic acids are suitable substrates. An electro-
philic alkyl bromide functional group is also tolerated (Scheme
5, entry 7c).
To explore additional reactivity types that diazo compounds
can engage in, we investigated the [3+2] cycloaddition of
diazomethyl-1,2-azaborine 1 with alkenes. A diazo compound
is typically considered electron-rich and thus reacts as a
nucleophile in normal-electron-demand cycloadditions with
electron-deficient dipolarophiles.33 We are pleased to find that
diazomethyl-1,2-azaborine 1 undergoes regioselective [3+2]
cycloaddition reactions with α,β-unsaturated esters, ketones,
and nitriles in the presence of a Pd catalyst to presumably
initially form intermediates 8′, which then subsequently
undergoes a formal 1,3-boryl shift to furnish adducts 8
(Scheme 6). In contrast, phenyldiazomethane preferentially
forms cyclopropane compounds with elimination of N2 (see
Supporting Information for experimental details). As an
additional comparison, while phenyldiazomethane reacts
relatively cleanly with styrene to furnish 1,2-diphenylcyclopro-
pane in the presence of cobalt(II) tetraphenylporphyrin,34
diazomethyl-1,2-azaborine 1 remains mostly unreactive,
producing minor amounts of the intramolecular C−H
activation product 6a (see Supporting Information for
experimental details).
Finally, we envisioned that diazomethyl-1,2-azaborine 1 can
serve as a precursor to the halomethyl building blocks 9 and 10
(Scheme 7). Benzyl halides are versatile intermediates in
diversity-oriented synthesis in medicinal chemistry,35 and
compounds 9 and 10 represent the direct BN isosteres of
benzylic halides. While examples of halomethyl BN naph-
thalenes have been reported,36 to the best of our knowledge,
such a building block for the monocyclic 1,2-azaborine
heterocycle has not been prepared. Importantly, the annulation
method involving potassium chloromethyltrifluoroborate and
2-aminostyrene to yield the chloromethyl BN naphthalenes36
is not applicable to the monocyclic benzene-type BN
heterocycle. We envisioned that similar to how O-alkylation
proceeds with protonation of the α-boryl carbon followed by
nucleophilic attack of the oxygen nucleophile,31 treatment of 1
with a suitably matched proton/halide source should yield the
corresponding halomethyl 1,2-azaborines 9 and 10.37 After
screening a number of conditions, we determined that 1-
ethynyl-4-nitrobenzene as the proton source in combination
with CuI as the iodide nucleophile works well for the
iodination of diazomethyl-1,2-azaborine 1 (Scheme 7, eq 8).
Similarly, the combination of bromoacetic acid as the proton
source and cetrimonium (hexadecyltrimethylammonium) bro-
mide is suitable for converting 1 to the bromomethyl 1,2-
azaborine 10 (Scheme 7, eq 9).38
can engage in Suzuki−Miyaura cross-coupling reaction to
produce BN diarylmethanes 11. Compound 10 also reacts with
a number of nucleophiles such as thiocyanate, azide, amine,
and phthalimide anion to furnish the corresponding adducts
12−15 in moderate to good yields, further demonstrating the
diversity of compounds that can be accessed with diazomethyl-
1,2-azaborine 1 as the universal precursor.
In summary, we synthesized the first α-boryl diazo
compound that is capable of engaging in classic synthetic
organic diazo reaction chemistry, including C−H activation,
O−H activation, [3+2] cycloaddition, halogenation, and Ru-
catalyzed carbonyl olefination. Furthermore, we showed that
diazomethyl-1,2-azaborine 1, a BN isostere of phenyldiazo-
methane, is a stable compound and that its corresponding Ru
carbene complex 3 exhibits bonding features that are distinct
from an analogous Ru-alkylidine complex. Overall, we believe
that diazomethyl-1,2-azaborine 1 as a new member of the α-
boryldiazo compound family and as a remarkably versatile 1,2-
azaborine building block will advance both the basic science of
diazo chemistry and the multifaceted chemistry of 1,2-
azaborine heterocycles.
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge at
■
sı
Experimental procedures, compound characterization
data, crystallographic information, and NMR spectra
for all new compounds (PDF)
Accession Codes
CCDC 2082462 contains the supplementary crystallographic
data for this paper. These data can be obtained free of charge
bridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
AUTHOR INFORMATION
Corresponding Author
■
Shih-Yuan Liu − Department of Chemistry, Boston College,
Chestnut Hill, Massachusetts 02467-3860, United States;
Authors
Yao Liu − Department of Chemistry, Boston College, Chestnut
Hill, Massachusetts 02467-3860, United States
Raimon Puig de la Bellacasa − Department of Organic and
̀
Pharmaceutical Chemistry, Institut Químic de Sarria,
Universitat Ramon Llull, E-08017 Barcelona, Spain
Bo Li − Department of Chemistry, Boston College, Chestnut
Hill, Massachusetts 02467-3860, United States
Ana Belén Cuenca − Department of Organic and
̀
Pharmaceutical Chemistry, Institut Químic de Sarria,
Universitat Ramon Llull, E-08017 Barcelona, Spain
Complete contact information is available at:
We chose bromomethyl 1,2-azaborine 10 to demonstrate the
ability of halomethyl 1,2-azaborines to serve as an electrophilic
building block in a variety of coupling and substitution
reactions.36,39 As can be seen from Scheme 8, compound 10
Author Contributions
The manuscript was written through contributions of all
authors. All authors have given approval to the final version of
the manuscript.
D
J. Am. Chem. Soc. XXXX, XXX, XXX−XXX